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ABSTRACT 
    
    Ischemia Reperfusion injury is the tissue damage caused when blood supply returns to the tissue after 
a period of ischemia or lack of oxygen. Ischemia Reperfusion induces cell death and endemic reaction 
that is one of the most important clinical problems with acute renal failure and renal transplantation. In 
this study, the effect of pentoxifylline on rat kidney function and cell injury following Ischemia 
Reperfusion were evaluated. In this experimental study, 20 male wistar rats with average weight of 250-
300g were selected and then were accidently divided them on two tenth group of control and treatment 
groups. In the control group, celiotomy was performed by ventral midline incision. The left kidney was 
isolated, and then both the renal artery and vein were obstructed. After 60 minutes of warm ischemia, 
vessel obstruction resolved and the right kidney was removed. 72 hours after reperfusion, tissue samples 
were taken from left kidney for histopathology. All these steps in treatment group were exactly repeated 
after administration of 45 mg/kg/PO pentoxifylline (3 hours before operation) and in this group treatment 
was continued every 12h until 3 days. In this research quantitative real-time PCR is used for the 
detection expression Bax gene in ischemia group and PNT drug group and  compared to  normal sample 
.The results showed the gene dosage ratio of 1.24 for ischemia groups  and 0.64 for drug group.  The 
results showed the expression Bax gene in PNT group  decline  than to  ischemia group.  Therefore, 
quantitative real time PCR could be used as a direct method for detection of Bax gene expression in 
tested and normal samples 
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INTRODUCTION   
    Ischemia-Reperfusion is a kind of complex 
clinical syndrome that in particular situation it 
might impress different body’s organs, as it is 
apparent from its name it has one level of 
reduction or obstruction  of perfusion to the 
tissue and after a  while reperfusion to that 
organ [1].If the cells involved in the reversal 
injury, reperfusion can improve the cells. 
However, in certain conditions blood 
recirculation to the ischemia tissues which are 
otherwise healthy repugnantly causes 
aggravation and worse damages in them. 
Consequently, In addition to the cells that were 
irreversibly damaged until the end of ischemia, 
the other cells already destroy in tissues. This 
state that called the ischemia-reperfusion injury, 
it’s an important clinical process that has a 
significance role in tissues destruction but it can 
be controlled with medical interventions [2,3]. 
Although, the exact mechanisms of injury are 
not known, one of the causes of injury 
(ischemia- reperfusion) stated as follow. Further 
blood perfusion in ischemia-reperfusion resulted 
in exacerbation locally absorption of 
inflammatory cells. These cells release large 
amounts of oxygen-derived active radicals and 
promote the membrane destruction process and 
mitochondrial permeability.  Increased 
permeability of mitochondria and formation of 
holes in mitochondrial membrane decrease the 
membrane potential, adenosine triphosphate 




production and swelling of mitochondria. 
Increase the permeability of mitochondrial outer 
membranes causes the releasing initiator inducer 
of apoptosis, the C cytochrome, into the cell 
cytosol. This process continued and moves on 
the proteolytic events and induces the apoptosis 
[4]. Ischemic acute renal failure is a clinical 
syndrome that occurs following obstruction or 
reduction in renal blood flow. Despite 
preventive measures and treatment of this 
disease is associated with high mortality [5]. 
Tissue damage begins from the same ischemic 
phase. Necrosis and apoptosis are two forms of 
cell injury. In necrosis, the cell elements come 
out of it and damage adjacent tissues. During 
apoptosis that is a programmable cell death, 
nucleus elements and cytoplasm are located 
within the vacuoles and then swallowed by 
macrophages without damaging to surrounding 
tissues [6, 7]. Reperfusion flowing to the initial 
phase of ischemia generates new type of injury 
to the body. According to indicated reason, 
these two sets together are called Ischemic 
Reperfusion (IR) [7]. New findings in this field 
emphasize the important role in ischemia 
reperfusion injury (1, 2). Several edematous 
mediators are released in the tissue which 
necrosis factor alpha (TNF-α), interleukin 1 and 
interleukin 6 are the most important one. The 
mediators generate and spread inflammatory 
phase in reperfusion. By increasing number of 
connection molecules (ICAM-1) on the surface 
of endothelial cells, the multi-nuclear cells are 
being entered into ischemic tissue. The entrance 
of multi-nuclear inflammatory cells is associated 
with the production of myeloperoxidase enzyme 
and then combination of nitric oxide with 
superoxide radicals and production of nitrite 
proxy individually causes the addition of 
oxidative stress to the inflammatory process that 
extend the range of ischemic injury and this 
reflects the pivotal role of inflammation in 
injury following ischemia reperfusion [8, 9]. In 
this study, the role of pentoxifylline drug on Bax 
gene expression changes in renal cells was 
examined. 
 
MATERIALS AND METHODS 
Animals 
In this experimental study, 20 adult wistar 
rats were selected and healthily function of 
renal of these animals was determined by 
measuring creatinine and blood urea nitrogen. 
Rats were randomly allocated into two 
control group (n=10) and treatment with 
pantoxyfylline group (n=10). In control 
group,for inducing anesthesia  about 12 
mg/kg  Ketamine  intraperitoneal by injection 
method was used. Celiotomy was performed 
by ventral midline incision the left kidney 
was isolated, and then both the renal artery 
and vein were obstructed. After 60 minutes 
ischemia, the vessels opened and reperfusion 
was performed. Then the right kidney was 
removed by using the nephrectomy. The time 
of blood reperfusion in this study was 3 days. 
After surgery, the animals were allowed to 
have free access to water. In treatment group 
with pantoxyfylline, all the actions above 
were done except t that this group had used 
pantoxyfylline dose of 45mg/kg orally 3 
hours before surgery. This treatment was 
continued once every 12 hours for 3 days. For 
microscopic studies, at the end of experiment 
and 72 hours after reperfusion, left kidney of 
rats separated by dislocation in neck vertebra. 
RNA isolation ,DNA digestion and  reverse 
transcription 
Tissue samples were   treated with TRI 
Reagent (SIGMA-Aldrich) as recommended 
by the manufacturer. The  extracted RNA was 
further purified using RNeasy mini kit 
(Qiagen)The concentration and purity of the 
purified RNA were determined  by 
spectrophotometry. High quality RNAs 
(A260/280≥1.8) were selected and kept at 
−80 °C until used for cDNA synthesis. Up to 
1 μg RNA was converted to cDNA using 
Quantitect® reverse transcription kit (Qiagen) 
according to the manufacturer's instruction. 
To verify the integrity of the cDNA, a PCR 
experiment was performed  using GAPDH 




specific primer. The primer for quantitation 
PCR of BCL2and GAPDH genes expression 
were designed by the Primer Express v.3.0 
software (Applied Biosystems, Foster City, 
USA). 
 Real-time PCR with SYBR green I 
The selected primers underwent an extensive 
search using BLAST tool 
(www.ncbi.nlm.nih.gov/blast) .The 
characteristics of the primers used in this 
study are summarized in Table 1. 
Real-time PCR was carried out in optical 
grade 96-well plates (Micro amp, Applied 
Bio systems, Singapore) at reaction volume 
of 25 macro Liter including   SYBR Green 
Master mix(primer design12/5)300nM  
primer and 5ng  genomic template DNA. All 
samples were run in duplicate Thermal 
cycling was performed on the Applied Bio 
systems 7300 real-time PCR system using 
the following cycling conditions: 95 °C for 
10 min, and 40 cycles at 95 °C for 15 s, and 
60 °C for 1 min. Each complete 
amplification stage was followed by a 
dissociation stage; at 95 °C for 15 s, 60 °C 
for 30 s, then temperature was ramped up 
from 60 °C to 95 °C (at the rate of 0.03 
°C/s), and fluorescence intensity data was 
collected continuously over the ramping 
stage for 20 min. Melting curve analysis was 
performed according to the dissociation 
stage data and reactions with a single peak at 
expected Tm were  considered for further 
analysis. 
Data analysis 
Quantitative analysis was performed by the 
measurement of CTvalues during the 
exponential phase of amplification. The Ct 
parameter was defined as the cycle number 
at which the amplification plot passed a 
fixed threshold. In each assay, m Ct was the 
mean Ct value of duplicate amplifications. 
Relative quantity of Bax gene was 
determined using comparative Ct method 
and Δ Ct was calculated as the difference 
between the Ct values of theBcl2 and the Ct 
value of GAPDH gene. The data were 
analyzed using the formula: Gene dosage 
ratio=2−ΔΔCt, where −ΔΔCt = [m Ct 
Bax(normal sample)−m Ct GAPDH gene 
(normal sample)]−[m Ct Bax (test sample)–m 
Ct GAPDH gene (test sampl)(29).  gene 
dosage ratios were determined relative to the 
mean Δ Ct value of these samples Data 
processing was performed using the ABI 
Prism 7300Sequence Detection System and 
the SDS software Ver. 1.2.3(Applied Bio 
systems, UK). Statistical analysis and graph 
preparation were performed using 









       pentoxifylline drug effect on Bax gene                         
expression changes in  kidney after  
ischemic/reperfusion in wistar  rat were tested   
by multiplex PCR . pentoxifylline drug effect 
on Bax gene    expression changes in   
hippocampus after  ischemic/reperfusion  was 
campared with ischemia group . Using this 
method tested    sample  and normal sample  
were analyzed. As expected, there was 
significant difference between the   tested  
and normal samples in multiplex PCR 
.Optimization and validation of real-time 
PCR assays (Figure1) . The gene dosage 
ratios obtained in each group were as follows: 




















Figure 1. Results of Real-time PCR analysis for expression 
of Bax and GAPDH genes.   
1,Bax gene 
2,NTC,  non-template control. 
3.GAPDH gene 
4.M, DNA Size marker 
 
the ischemia group  of bcl2 gene expression   
showed the ratios of 1.24.group  drug  of the 
Bax gene expression  experiments had the 
ratios of  0.64 (p<0.01). 
 
DISCUSSION 
Apoptosis, or programmed cell death, which 
can be distinguished on the basis of 
morphologic and biochemical criteria,is 
different from necrosis (11–13). The 
mechanism responsible for post-I/R apoptosis 
is attributed to the increasing activity of 
endonuclease by elevation of calcium entry 
into cells (14), or the release of reactive 
oxygen species (ROS) (14 –16). 
ROS induce apoptosis by causing DNA 
damage, oxidation of lipid membranes, and/or 
direct activation and expression of the 
genes/proteins responsible for apoptosis (17). 
For example, increases in the Bax/Bcl-2 ratio 
(18), expression of caspase and its activity 
(19,20), and caspase-mediated cleavage of 
poly- (ADP-ribose)-polymerase (PARP) (21) 
have been found in organs subjected to I/R 
injury or in cells after a cytotoxic insult. 
The sources of ROS generated after I/R may 
be circulatory macrophages/neutrophils (22) 
or the resident cells (23).  
In the kidney, demonstration of increased 
renal venous ROS after I/R by electron spin 
resonance and the efficacy of antioxidants or 
free-radical scavengers in minimizing I/R 
injury (14,16) suggest a role of ROS in I/R 
injury. However, the precise origin of ROS in 
the I/R kidney has yet to be defined. 
The inflammatory response partially mediates 
the damage of reperfusion injury. As 
pentoxifylline is reducing inflammatory 
processes; therefore, it directly reduces the 
production of growth factors produced from 
leukocytes in the inflammatory process that 
the higher expression of FGF & IGF In the 
process of ischemia-reperfusion of other 
pathways causes cell death. FGF from MAPK 
way and ERK cause the activation of Bax 
pathway and formation of mitochondrial 
channels and by facilitating the exit of C 
cytochrome, induces cell death.  IGF o 
through PI3K also causes the activation of 
AKT/PKB and the function of Bax protein 
and BCL2 .Therefore, the pathway of cell 
death is going to be started, by forming 
mitochondrial membrane channel and exiting 
of C cytochrome.  
The role of Fas ligand in the induction of cell 
death after reperfusion should not be 
forgotten which exert its cell death effect 
through FADD pathway and caspases 1, 3, 4, 
6, 7&8. Because all the agents that been 
mentioned are effective in cell death of renal 
tubules, it’s clear that the effects of 
pentoxifylline on cellular and vascular events, 
edematous process, inhibition of banding 
molecules, inhibition of inflammatory cells 
out, reduction of edematous mediators’ 
production, cytokines (IL-α, TNF-α , IL-8 , 
IL-6 ,IL-1β,I) and growth factors can be 
effective in reducing and inhibiting cell death 
in the treatment group [24].  





    In this study we have designed and 
optimized quantitative real-time PCR assays 
based on  SYBR Green I chemistry for 
determining the PTX drug effect on Bax gene 
expression changes in kidney after ischemic 
/reperfusion in  rat. 
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